Ekso Bionics Holdings, Inc.
EKSO
$3.92
$0.082.08%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -10.14% | 5.01% | -10.38% | 5.25% | -8.88% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -10.14% | 5.01% | -10.38% | 5.25% | -8.88% |
| Cost of Revenue | -13.07% | -4.12% | -10.74% | -5.55% | -14.94% |
| Gross Profit | -7.43% | 14.56% | -10.06% | 16.99% | -2.45% |
| SG&A Expenses | 0.17% | -7.24% | -3.71% | -24.98% | -23.10% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.38% | -11.76% | -10.21% | -18.94% | -18.18% |
| Operating Income | -0.12% | 35.34% | 9.96% | 45.49% | 26.80% |
| Income Before Tax | 15.69% | -6.19% | 38.42% | 42.88% | 21.87% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.69% | -6.19% | 38.42% | 42.88% | 21.87% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.69% | -6.19% | 38.42% | 42.88% | 21.87% |
| EBIT | -0.12% | 35.34% | 9.96% | 45.49% | 26.80% |
| EBITDA | -1.12% | 39.28% | 10.97% | 49.74% | 29.35% |
| EPS Basic | 42.15% | 37.75% | 57.34% | 57.25% | 40.35% |
| Normalized Basic EPS | 44.00% | 37.74% | 57.30% | 57.25% | 42.27% |
| EPS Diluted | 42.15% | 38.80% | 57.34% | 57.25% | 40.35% |
| Normalized Diluted EPS | 44.00% | 37.74% | 57.30% | 57.25% | 42.27% |
| Average Basic Shares Outstanding | 45.78% | 70.57% | 44.32% | 33.64% | 31.01% |
| Average Diluted Shares Outstanding | 45.78% | 70.57% | 44.32% | 33.64% | 31.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |